Table 2 Efficacy of taxane plus ramucirumab.

From: Efficacy and safety of taxane plus ramucirumab for advanced gastric cancer after chemotherapy plus nivolumab

 

All (n = 43)

PTX + RAM (n = 33)

Nab-PTX + RAM (n = 10)

Response rate (%)

21

27

0

Disease control rate (%)

70

67

80

PFS (months)

3.7

3.3

4.2

OS (months)

8.9

8.9

6.9

Back to article page